Cargando…
A Phase 2a Randomized Study to Evaluate the Safety and Immunogenicity of the 1790GAHB Generalized Modules for Membrane Antigen Vaccine against Shigella sonnei Administered Intramuscularly to Adults from a Shigellosis-Endemic Country
Shigellosis is a mild-to-severe diarrheal infection, caused by the genus Shigella, and is responsible for significant morbidity and mortality worldwide. We evaluated the safety and immunogenicity of an investigational Shigella sonnei vaccine (1790GAHB) based on generalized modules for membrane antig...
Autores principales: | Obiero, Christina W., Ndiaye, Augustin G. W., Sciré, Antonella Silvia, Kaunyangi, Bonface M., Marchetti, Elisa, Gone, Ann M., Schütte, Lena Dorothee, Riccucci, Daniele, Auerbach, Joachim, Saul, Allan, Martin, Laura B., Bejon, Philip, Njuguna, Patricia, Podda, Audino |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5763125/ https://www.ncbi.nlm.nih.gov/pubmed/29375556 http://dx.doi.org/10.3389/fimmu.2017.01884 |
Ejemplares similares
-
Booster Vaccination With GVGH Shigella sonnei 1790GAHB GMMA Vaccine Compared to Single Vaccination in Unvaccinated Healthy European Adults: Results From a Phase 1 Clinical Trial
por: Launay, Odile, et al.
Publicado: (2019) -
GMMA Technology for the Development of Safe Vaccines: Meta-Analysis of Individual Patient Data to Assess the Safety Profile of Shigella sonnei 1790GAHB Vaccine in Healthy Adults, with Special Focus on Neutropenia
por: De Ryck, Iris, et al.
Publicado: (2022) -
Production of a Shigella sonnei Vaccine Based on Generalized Modules for Membrane Antigens (GMMA), 1790GAHB
por: Gerke, Christiane, et al.
Publicado: (2015) -
Correction to: GMMA Technology for the Development of Safe Vaccines: Meta-Analysis of Individual Patient Data to Assess the Safety Profile of Shigella sonnei 1790GAHB Vaccine in Healthy Adults, with Special Focus on Neutropenia
por: De Ryck, Iris, et al.
Publicado: (2022) -
Efficacy, safety, and immunogenicity of the Shigella sonnei 1790GAHB GMMA candidate vaccine: Results from a phase 2b randomized, placebo-controlled challenge study in adults
por: Frenck, Robert W., et al.
Publicado: (2021)